The warning from researchers comes amid the potential myriad of therapeutic benefits of GLP-1 receptor agonists beyond diabetes and obesity
Second, the surgical answer is not the only answer
In the type 2 diabetes mellitus subpopulation, at baseline, the mean eGFR was 36 mL/min/1.73 m2, 17% of patients had an eGFR equal to or above 45 mL/min/1.73 m2, and 45% had an eGFR 30 to less than 45 mL/min/1.73 m2
Patients who are pregnant, planning pregnancy, breastfeeding, or dealing with certain medical conditions may need a different approach
So then the next question just becomes, how do we build a regulatory pathway in this, in this country that allows accessibility so that Americans aren't having to go to other nations